. . . . . . . . "This review summarize the present knowledge of IFN-β mechanism of action, the overall safety, and the short- and long-term efficacy of its use in relapsing remitting Multiple Sclerosis and clinically isolated syndromes" . . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" . "T3fLNiy+/2ru+XP+yYYwO1Xx7fATvuM7CpYoGaxbCiqKJ5A7kDH5XpD6/mpG0AQv80Ed6IwEBn/6pxx7hlScs8TQVY7Wgpi4kZybc6RjykPdTfXMuJyw3vhzhO003JEyF6utw4/mdOqL/GT0VnyyfIoHJTK9jC8V9ByVlOT2XQ0=" . . "2021-09-07T16:02:59.517+02:00"^^ . . . . .